BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 37483588)

  • 1. A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans.
    Rebaudi F; De Rosa A; Greppi M; Pistilli R; Pucci R; Govoni FA; Iacoviello P; Broccolo F; Tomasello G; Pesce S; Laganà F; Bianchi B; Di Gaudio F; Rebaudi A; Marcenaro E
    Front Immunol; 2023; 14():1216107. PubMed ID: 37483588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of salivary Cathepsin B in different histological grades among patients presenting with oral squamous cell carcinoma.
    Shabbir A; Waheed H; Ahmed S; Shaikh SS; Farooqui WA
    BMC Oral Health; 2022 Mar; 22(1):63. PubMed ID: 35260133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validation of a saliva-based matrix metalloproteinase-1 rapid strip test for detection of oral cavity cancer.
    Chu LJ; Chang YT; Chien CY; Chung HC; Wu SF; Chen CJ; Liu YC; Liao WC; Chen CH; Chiang WF; Chang KP; Wang JS; Yu JS
    Biomed J; 2024 Feb; 47(1):100594. PubMed ID: 37044249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of tumor marker CA 125 in saliva of normal and oral squamous cell carcinoma patients: a comparative study.
    Balan JJ; Rao RS; Premalatha BR; Patil S
    J Contemp Dent Pract; 2012 Sep; 13(5):671-5. PubMed ID: 23250173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
    Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
    Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of trefoil factor expression in saliva and oral mucosal tissues of patients with oral squamous cell carcinoma.
    Chaiyarit P; Utrawichian A; Leelayuwat C; Vatanasapt P; Chanchareonsook N; Samson MH; Giraud AS
    Clin Oral Investig; 2012 Dec; 16(6):1549-56. PubMed ID: 22205269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.
    Csősz É; Lábiscsák P; Kalló G; Márkus B; Emri M; Szabó A; Tar I; Tőzsér J; Kiss C; Márton I
    PLoS One; 2017; 12(5):e0177282. PubMed ID: 28545132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer.
    Horváth J; Szabó A; Tar I; Dezső B; Kiss C; Márton I; Scholtz B
    Pathol Oncol Res; 2018 Oct; 24(4):833-842. PubMed ID: 28861772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Salivary Biomarkers in Oral Cancer Detection.
    Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
    Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of selected salivary inflammatory cytokines in the diagnosis and prognosis of oral squamous cell carcinoma. A Systematic Review and Meta-analysis.
    Benito-Ramal E; Egido-Moreno S; González-Navarro B; Jané-Salas E; Roselló-Llabrés X; López-López J
    Med Oral Patol Oral Cir Bucal; 2023 Sep; 28(5):e474-e486. PubMed ID: 37099710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.
    Gleber-Netto FO; Yakob M; Li F; Feng Z; Dai J; Kao HK; Chang YL; Chang KP; Wong DT
    Clin Cancer Res; 2016 Jul; 22(13):3340-7. PubMed ID: 26847061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
    Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
    Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased salivary AKR1B10 level: Association with progression and poor prognosis of oral squamous cell carcinoma.
    Ko HH; Peng HH; Cheng SJ; Kuo MY
    Head Neck; 2018 Dec; 40(12):2642-2647. PubMed ID: 30430672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
    Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
    J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Saliva and Serum miRNA Panel as a Potential Useful Index for Oral Cancer and the Association of miR-21 with Smoking History: a Pilot Study.
    Vageli DP; Doukas PG; Shah R; Boyi T; Liu C; Judson BL
    Cancer Prev Res (Phila); 2023 Dec; 16(12):653-659. PubMed ID: 37683274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma.
    Nakamichi E; Sakakura H; Mii S; Yamamoto N; Hibi H; Asai M; Takahashi M
    Oral Dis; 2021 Apr; 27(3):439-447. PubMed ID: 32688445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care Analysis for Non-invasive Diagnosis of Oral cancer (PANDORA): A technology-development proof of concept diagnostic accuracy study of dielectrophoresis in patients with oral squamous cell carcinoma and dysplasia.
    Hughes MP; Labeed FH; Hoettges KF; Porter S; Mercadante V; Kalavrezos N; Liew C; McCaul JA; Kulkarni R; Cymerman J; Kerawala C; Barber J; Lewis MP; Fedele S
    J Oral Pathol Med; 2023 Apr; 52(4):305-314. PubMed ID: 36811206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
    Elmahgoub F
    Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study.
    Gholami S; Chamorro-Petronacci C; Pérez-Sayáns M; Suárez Peñaranda J; Longatto-Filho A; Baltazar F; Afonso J
    J Appl Oral Sci; 2023; 31():e20220461. PubMed ID: 37194791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.
    Satgunaseelan L; Gupta R; Madore J; Chia N; Lum T; Palme CE; Boyer M; Scolyer RA; Clark JR
    Pathology; 2016 Oct; 48(6):574-80. PubMed ID: 27590194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.